
Hancom


DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease and related conditions Together, we believe we can transform the future of patient care for the better
We aim to invest in, acquire, and co-develop products, solutions and businesses that improve care for patients with kidney disease and related conditions Advancements to expand access to care and improve clinical outcomes through adoption of tech-enabled services, home treatments and value-based care Pharmaceuticals, medical devices and diagnostics that can improve clinical outcomes and patient experience while reducing costs Products and services that leverage technology, data and connectivity to improve care delivery We look to invest in early-to-mid stage, growth-oriented businesses that share our mission to transform health care
We strive to collaborate with partners in developing, testing and bringing new technologies to market We also look to contribute clinical and operational expertise, product development resources, data insights and more
We aspire to accelerate DaVita’s strategy by bringing new technology and talent into the organization through mergers and acquisitions
Interested in working with DaVita Venture Group? Please fill out the form We will contact you shortly
I understand my information will be handled in accordance with the DaVita Privacy Policy and Terms of Use
Thank you for your interest We will be in touch shortly
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about DaVita Venture Group.
Similar listings buyers compare against this one.

Hancom

Applied Materials

Boston Scientific

Techstars

Kleiner Perkins Caufield & Byers

Coinbase Ventures
Everything here links back to the same verified catalogue. Pick your next stop.